The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2010

Filed:

Apr. 24, 2007
Applicants:

Philip D. Stein, Pennington, NJ (US);

Steven P. Seitz, Swarthmore, PA (US);

David J. Carini, Wallingford, CT (US);

Yan Shi, Flourtown, PA (US);

Jeffrey A. Robl, Newtown, PA (US);

Jay A. Markwalder, New London, PA (US);

Chunhong He, Boothwyn, PA (US);

Inventors:

Philip D. Stein, Pennington, NJ (US);

Steven P. Seitz, Swarthmore, PA (US);

David J. Carini, Wallingford, CT (US);

Yan Shi, Flourtown, PA (US);

Jeffrey A. Robl, Newtown, PA (US);

Jay A. Markwalder, New London, PA (US);

Chunhong He, Boothwyn, PA (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/42 (2006.01); A61K 31/44 (2006.01); C07D 221/18 (2006.01); C07D 221/22 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds are provided of the following structure are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and treating hyperlipidemia and dyslipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis wherein variables A and B are defined herein.


Find Patent Forward Citations

Loading…